JACS Au (May 2021)
Cov-MS: A Community-Based Template Assay for Mass-Spectrometry-Based Protein Detection in SARS-CoV‑2 Patients
- Bart Van Puyvelde,
- Katleen Van Uytfanghe,
- Olivier Tytgat,
- Laurence Van Oudenhove,
- Ralf Gabriels,
- Robbin Bouwmeester,
- Simon Daled,
- Tim Van Den Bossche,
- Pathmanaban Ramasamy,
- Sigrid Verhelst,
- Laura De Clerck,
- Laura Corveleyn,
- Sander Willems,
- Nathan Debunne,
- Evelien Wynendaele,
- Bart De Spiegeleer,
- Peter Judak,
- Kris Roels,
- Laurie De Wilde,
- Peter Van Eenoo,
- Tim Reyns,
- Marc Cherlet,
- Emmie Dumont,
- Griet Debyser,
- Ruben t’Kindt,
- Koen Sandra,
- Surya Gupta,
- Nicolas Drouin,
- Amy Harms,
- Thomas Hankemeier,
- Donald J. L. Jones,
- Pankaj Gupta,
- Dan Lane,
- Catherine S. Lane,
- Said El Ouadi,
- Jean-Baptiste Vincendet,
- Nick Morrice,
- Stuart Oehrle,
- Nikunj Tanna,
- Steve Silvester,
- Sally Hannam,
- Florian C. Sigloch,
- Andrea Bhangu-Uhlmann,
- Jan Claereboudt,
- N. Leigh Anderson,
- Morteza Razavi,
- Sven Degroeve,
- Lize Cuypers,
- Christophe Stove,
- Katrien Lagrou,
- Geert A. Martens,
- Dieter Deforce,
- Lennart Martens,
- Johannes P. C. Vissers,
- Maarten Dhaenens
Affiliations
- Bart Van Puyvelde
- ProGenTomics, Laboratory of Pharmaceutical Biotechnology, Ghent University, Ghent, Belgium
- Katleen Van Uytfanghe
- Laboratory of Toxicology, Department of Bioanalysis, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium
- Olivier Tytgat
- ProGenTomics, Laboratory of Pharmaceutical Biotechnology, Ghent University, Ghent, Belgium
- Laurence Van Oudenhove
- Waters Corporation, Antwerp, Belgium
- Ralf Gabriels
- VIB-UGent Center for Medical Biotechnology, VIB, Ghent, Belgium
- Robbin Bouwmeester
- VIB-UGent Center for Medical Biotechnology, VIB, Ghent, Belgium
- Simon Daled
- ProGenTomics, Laboratory of Pharmaceutical Biotechnology, Ghent University, Ghent, Belgium
- Tim Van Den Bossche
- VIB-UGent Center for Medical Biotechnology, VIB, Ghent, Belgium
- Pathmanaban Ramasamy
- VIB-UGent Center for Medical Biotechnology, VIB, Ghent, Belgium
- Sigrid Verhelst
- ProGenTomics, Laboratory of Pharmaceutical Biotechnology, Ghent University, Ghent, Belgium
- Laura De Clerck
- ProGenTomics, Laboratory of Pharmaceutical Biotechnology, Ghent University, Ghent, Belgium
- Laura Corveleyn
- ProGenTomics, Laboratory of Pharmaceutical Biotechnology, Ghent University, Ghent, Belgium
- Sander Willems
- ProGenTomics, Laboratory of Pharmaceutical Biotechnology, Ghent University, Ghent, Belgium
- Nathan Debunne
- Drug Quality and Registration Group, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium
- Evelien Wynendaele
- Drug Quality and Registration Group, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium
- Bart De Spiegeleer
- Drug Quality and Registration Group, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium
- Peter Judak
- Doping Control Laboratory, Department of Diagnostic Sciences, Ghent University, Ghent, Belgium
- Kris Roels
- Doping Control Laboratory, Department of Diagnostic Sciences, Ghent University, Ghent, Belgium
- Laurie De Wilde
- Doping Control Laboratory, Department of Diagnostic Sciences, Ghent University, Ghent, Belgium
- Peter Van Eenoo
- Doping Control Laboratory, Department of Diagnostic Sciences, Ghent University, Ghent, Belgium
- Tim Reyns
- Department of Clinical Chemistry, Ghent University Hospital, Ghent, Belgium
- Marc Cherlet
- Department of Pharmacology, Toxicology, and Biochemistry, Faculty of Veterinary Medicine, Ghent University, Ghent, Belgium
- Emmie Dumont
- Research Institute for Chromatography (RIC), Kortrijk, Belgium
- Griet Debyser
- Research Institute for Chromatography (RIC), Kortrijk, Belgium
- Ruben t’Kindt
- Research Institute for Chromatography (RIC), Kortrijk, Belgium
- Koen Sandra
- Research Institute for Chromatography (RIC), Kortrijk, Belgium
- Surya Gupta
- VIB-UGent Center for Medical Biotechnology, VIB, Ghent, Belgium
- Nicolas Drouin
- Division of Systems Biomedicine and Pharmacology, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands
- Amy Harms
- Division of Systems Biomedicine and Pharmacology, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands
- Thomas Hankemeier
- Division of Systems Biomedicine and Pharmacology, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands
- Donald J. L. Jones
- Leicester Cancer Research Centre, RKCSB, University of Leicester, U.K., and John and Lucille van Geest Biomarker Facility, Cardiovascular Research Centre, Glenfield Hospital, Leicester, United Kingdom
- Pankaj Gupta
- The Department of Chemical Pathology and Metabolic Diseases, Level 4, Sandringham Building, Leicester Royal Infirmary, Leicester, United Kingdom
- Dan Lane
- The Department of Chemical Pathology and Metabolic Diseases, Level 4, Sandringham Building, Leicester Royal Infirmary, Leicester, United Kingdom
- Catherine S. Lane
- AB Sciex, Macclesfield, United Kingdom
- Said El Ouadi
- AB Sciex, Macclesfield, United Kingdom
- Jean-Baptiste Vincendet
- AB Sciex, Macclesfield, United Kingdom
- Nick Morrice
- AB Sciex, Macclesfield, United Kingdom
- Stuart Oehrle
- Waters Corporation, Milford, Massachusetts, United States
- Nikunj Tanna
- Waters Corporation, Milford, Massachusetts, United States
- Steve Silvester
- Alderley Analytical, Macclesfield, United Kingdom
- Sally Hannam
- Alderley Analytical, Macclesfield, United Kingdom
- Florian C. Sigloch
- Polyquant GmbH, Bad Abbach, Germany
- Andrea Bhangu-Uhlmann
- Polyquant GmbH, Bad Abbach, Germany
- Jan Claereboudt
- Waters Corporation, Antwerp, Belgium
- N. Leigh Anderson
- SISCAPA Assay Technologies, Inc., Washington, D.C., United States
- Morteza Razavi
- SISCAPA Assay Technologies, Inc., Washington, D.C., United States
- Sven Degroeve
- VIB-UGent Center for Medical Biotechnology, VIB, Ghent, Belgium
- Lize Cuypers
- Clinical Department of Laboratory Medicine, UZ Leuven, Leuven, Belgium
- Christophe Stove
- Laboratory of Toxicology, Department of Bioanalysis, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium
- Katrien Lagrou
- Clinical Department of Laboratory Medicine, UZ Leuven, Leuven, Belgium
- Geert A. Martens
- AZ Delta Medical Laboratories, AZ Delta General Hospital, Roeselare, Belgium
- Dieter Deforce
- ProGenTomics, Laboratory of Pharmaceutical Biotechnology, Ghent University, Ghent, Belgium
- Lennart Martens
- VIB-UGent Center for Medical Biotechnology, VIB, Ghent, Belgium
- Johannes P. C. Vissers
- Waters Corporation, Milford, Massachusetts, United States
- Maarten Dhaenens
- ProGenTomics, Laboratory of Pharmaceutical Biotechnology, Ghent University, Ghent, Belgium
- DOI
- https://doi.org/10.1021/jacsau.1c00048
- Journal volume & issue
-
Vol. 1,
no. 6
pp. 750 – 765
Abstract
No abstracts available.